Our Mission
The ACC Nevada Chapter is dedicated to advancing the field of cardiovascular care through innovation, advocacy, and professional development, ensuring that Nevada’s clinicians are equipped to meet the evolving health challenges of our state.
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- Governance in Action: Updates From ACC's October Board of Trustees MeetingACC's October Board of Trustees (BOT) meeting was rich with strategic dialogue and forward-looking initiatives that reflect our shared commitment to advancing cardiovascular care and strengthening the ACC community.
- Government Shutdown Ends With Legislation That Extends Medicare Telehealth FlexibilitiesCongress passed legislation on Nov. 12 to fund the federal government, and shortly after, President Donald Trump signed the continuing resolution into law, ending the longest ever government shutdown after 43 days of gridlock.
- PISCES: Fish Oil Reduces CV Event Risk in Patients on DialysisPatients on maintenance hemodialysis receiving daily fish oil had significantly lower rates of serious cardiovascular events than those receiving placebo, according to the PISCES trial, presented at the American Society of Nephrology Kidney Week Annual Meeting and simultaneously published Nov. 7 in NEJM.
- Eagle’s Eye View: Highlights from the 2025 AHA Scientific SessionsIn this week’s View, Dr. Eagle highlights several important studies presented at the recent American Heart Association Scientific Sessions.
- ACCEL Lite: TACSI Trial: Dual or Single Antiplatelet Therapy After CABG in Patients With ACSIn this interview, Drs. Steven E. Nissen and Anders Jeppsson discuss “TACSI Trial: Dual or Single Antiplatelet Therapy After CABG in Patients With ACSâ€.